Benzydamine
- BENZYDAMINE
- 642-72-8
- Benzidamine
- Benzindamine
- Bencidamina
- Create:2005-03-27
- Modify:2024-12-27
- Benzidamine
- Benzindamine
- Benzydamine
- Benzydamine Hydrochloride
- Benzydamine Monohydrochloride
- Difflam
- Hydrochloride, Benzydamine
- Lonol
- Monohydrochloride, Benzydamine
- Novo Benzydamine
- Novo-Benzydamine
- Opalgyne
- PMS Benzydamine
- PMS-Benzydamine
- ratio Benzydamine
- ratio-Benzydamine
- Rosalgin
- Sun Benz
- Sun-Benz
- Tantum
- Tantum Topico
- BENZYDAMINE
- 642-72-8
- Benzidamine
- Benzindamine
- Bencidamina
- Benzydaminum
- Benzidamina
- Apo-Benzydamine
- Benzidamina [DCIT]
- Benzydamine [INN:BAN]
- benzydamide
- Benzydaminum [INN-Latin]
- Bencidamina [INN-Spanish]
- 3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine
- 1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole
- Benzydamine (INN)
- Apo-Benzydamine (TN)
- EINECS 211-388-8
- C 1523
- Difflam
- UNII-4O21U048EF
- BRN 0896536
- 1H-Indazole, 1-benzyl-3-(3-(dimethylamino)propoxy)-
- 4O21U048EF
- 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-
- {3-[(1-benzyl-1H-indazol-3-yl)oxy]propyl}dimethylamine
- BENZYDAMINE [MI]
- BENZYDAMINE [INN]
- 1-Benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole
- BENZYDAMINE [WHO-DD]
- DTXSID7047859
- CHEBI:94563
- 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
- 5-23-11-00248 (Beilstein Handbook Reference)
- Benzydaminum (INN-Latin)
- Tantum (TN)
- Bencidamina (INN-Spanish)
- 1-BENZYL-1H-INDAZOL-3-YL 3-(DIMETHYLAMINO)PROPYL ETHER
- 3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-amine
- 3-[(1-benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-aminie
- N,N-dimethyl-3-[[1-(phenylmethyl)-3-indazolyl]oxy]-1-propanamine
- N,N-DIMETHYL-3-((1-(PHENYLMETHYL)-1H-INDAZOL-3-YL)OXY)-1-PROPANAMINE
- NCGC00016397-01
- CAS-132-69-4
- (3-((1-benzyl-1H-indazol-3-yl)oxy)propyl)dimethylamine
- Benzydamine Monohydrochloride
- Monohydrochloride, Benzydamine
- 3-((1-benzyl-1H-indazol-3-yl)oxy)-N,N-dimethylpropan-1-aminie
- N,N-dimethyl-3-((1-(phenylmethyl)-3-indazolyl)oxy)-1-propanamine
- SR-01000799149
- Prestwick0_000297
- Prestwick1_000297
- Prestwick2_000297
- Prestwick3_000297
- SCHEMBL26172
- BSPBio_000234
- CHEMBL12610
- SPBio_002453
- BPBio1_000258
- DTXCID7027835
- G02CC03
- M01AX05
- M02AA05
- R02AX03
- HMS2090P22
- ALBB-027259
- BBL009932
- BDBM50103598
- STK711092
- AKOS005530662
- DB09084
- SB16913
- NCGC00016397-02
- NCGC00016397-07
- AC-15604
- HY-30235
- TS-09888
- SBI-0206866.P001
- CS-0000176
- NS00009149
- D07516
- G78294
- 1benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole
- EN300-12576563
- Q793143
- SR-01000799149-2
- BRD-K28542495-001-01-4
- BRD-K28542495-003-03-6
- BRD-K28542495-003-07-7
- BRD-K28542495-003-12-7
- BRD-K28542495-003-13-5
- 3-(1-benzyl-1H-indazol-3-yloxy)-N,N-dimethylpropan-1-amine
- N-(3-[(1-Benzyl-1H-indazol-3-yl)oxy]propyl)-N,N-dimethylamine #
174.24 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
169.91 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
173.82 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
M - Musculo-skeletal system
M02 - Topical products for joint and muscular pain
M02A - Topical products for joint and muscular pain
M02AA - Antiinflammatory preparations, non-steroids for topical use
M02AA05 - Benzydamine
A - Alimentary tract and metabolism
A01 - Stomatological preparations
A01A - Stomatological preparations
A01AD - Other agents for local oral treatment
A01AD02 - Benzydamine
R - Respiratory system
R02 - Throat preparations
R02A - Throat preparations
R02AX - Other throat preparations
R02AX03 - Benzydamine
<b>Use (kg; approx.) in Germany (2009):</b> >50
<b>Consumption (g per capita; approx.) in Germany (2009):</b> 0.000611
<b>Calculated removal (%):</b> 58.4
IMAP assessments - 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-: Environment tier I assessment
IMAP assessments - 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-: Human health tier I assessment
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=CNBGNNVCVSKAQZ-UHFFFAOYSA-N
- Australian Industrial Chemicals Introduction Scheme (AICIS)1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-https://services.industrialchemicals.gov.au/search-assessments/
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/
- ChemIDplusBenzydamine [INN:BAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000642728ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_useBenzydaminehttps://www.drugbank.ca/drugs/DB09084
- EPA DSSToxCompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-notice
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linking
- CCSbaseCCSbase Classificationhttps://ccsbase.net/
- ChEBI
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licence
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jsp
- Therapeutic Target Database (TTD)
- EU Clinical Trials Register
- Human Metabolome Database (HMDB)LICENSEHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.http://www.hmdb.ca/citingBENZYDAMINEhttp://www.hmdb.ca/metabolites/HMDB0249061
- Japan Chemical Substance Dictionary (Nikkaji)
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegTarget-based classification of drugshttp://www.genome.jp/kegg-bin/get_htext?br08310.keg
- Metabolomics Workbench
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NIST Mass Spectrometry Data CenterLICENSEData covered by the Standard Reference Data Act of 1968 as amended.https://www.nist.gov/srd/public-law1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-http://www.nist.gov/srd/nist1a.cfm
- SpectraBaseBenzydaminehttps://spectrabase.com/spectrum/IxxTloG3uroBenzydaminehttps://spectrabase.com/spectrum/84Y8RvDxIbU1-benzyl-3-[3-(dimethylamino)propoxy]-1H-indazolehttps://spectrabase.com/spectrum/IH3E8KbqMxD1-BENZYL-3-[3-(DIMETHYLAMINO)PROPOXY]-1H-INDAZOLEhttps://spectrabase.com/spectrum/5JdII0lUgUa1H-INDAZOLE, 1-BENZYL-3-/3-/DIMETHYL- AMINO/PROPOXY/-,https://spectrabase.com/spectrum/DAl7hWAcVzU
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/BENZYDAMINENORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- Springer Nature
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- WHO Anatomical Therapeutic Chemical (ATC) ClassificationLICENSEUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.https://www.whocc.no/copyright_disclaimer/
- Wikidatabenzydaminehttps://www.wikidata.org/wiki/Q793143
- WikipediaBenzydaminehttps://en.wikipedia.org/wiki/Benzydamine
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlBenzydaminehttps://www.ncbi.nlm.nih.gov/mesh/68001591Anti-Inflammatory Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000893
- PubChem
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 403409948https://pubchem.ncbi.nlm.nih.gov/substance/403409948
- NCBI